YCBD cbdMD Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Sumichrast Martin A.	2. Issuer Name and Ticker or Trading Symbol cbdMD, Inc. [ YCBD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chairman & CO-CEO
(Last)          (First)          (Middle) C/O 8845 RED OAK BLVD	3. Date of Earliest Transaction (MM/DD/YYYY) 4/19/2012
(Street) CHARLOTTE, NC 28217 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (1)	$3.39	4/19/2021		A		250000		1/1/2022	1/1/2027	Common stock	250000	$0	250000	D
stock option (1)	$3.39	4/19/2021		A		250000		1/1/2023	1/1/2028	Common stock	250000	$0	250000	D
Stock option (1)	$3.39	4/19/2021		A		250000		1/1/2024	1/1/2029	Common stock	250000	$0	250000	D
Restricted stock award (2)	$0	4/19/2021		A		250000		1/1/2022	1/1/2022	Common stock	250000	$0	250000	D
Restricted stock award (2)	$0	4/19/2021		A		250000		1/1/2023	1/1/2023	Common stock	250000	$0	250000	D
Restricted stock award (2)	$0	4/19/2021		A		250000		1/1/2024	1/1/2024	Common stock	250000	$0	250000	D

Explanation of Responses:
(1)	Represents grants of stock options to the Reporting Person under the Issuer's 2021 Equity Compensation Plan (the "2021 Plan") pursuant to the terms and conditions of the Amended and Restated Executive Employment Agreement dated April 19, 2012 by and between the Issuer and the Reporting Person (the "Sumichrast Employment Agreement").
(2)	Represents grants of restricted stock awards to the Reporting Person under the 2021 Plan pursuant to the terms and conditions of the Sumichrast Employment Agreement.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Sumichrast Martin A. C/O 8845 RED OAK BLVD CHARLOTTE, NC 28217	X		Chairman & CO-CEO

Signatures
/s/ Martin A. Sumichrast		4/20/2021
**Signature of Reporting Person		Date